The global “alopecia treatment market” size is estimated to reach USD 13.45 Billion by 2027 on account of the increasing number of hair loss cases in people irrespective of gender and age. Alopecia areata is a medical condition that results in hair loss in patches for both males and females. The immune system of the body attacks the hair follicles and ultimately results in loss of hair on the scalp, eyebrows, eyelashes, and face.
According to a recent report by Fortune Business Insights titled, “Alopecia Treatment Market Size, Share & Industry Analysis, By Route of Administration (Topical, Injectable, Oral), By Gender Type (Male, Female), By Age Group (Below 18 years, 18 – 34 Years, 35 – 49 Years, Above 50 Years), By End User (Hospitals and Physician Offices, Dermatology Clinics, Others) and Regional Forecast, 2020-2027,” the market value stood at USD 8.89 Billion in 2019 and is anticipated to rise at a CAGR of 5.2% between 2020 to 2027.
Massive Investments on Clinicals will Augment Growth
Various factors are responsible for the alopecia treatment of market growth. These include increasing adoption of a sedentary lifestyle, binge eating habits, cigarette consumption, and others that ultimately weaken the immune system. In addition to this, there is heavy investment in hair transplantation systems, and this will also add impetus to the market in the forecast period.
On the flip side, factors such as the side effects associated with this treatment procedure such as ejaculation disorders, impotency, enlargement or tenderness of breasts, and testicular pain may pose a major hindrance to the market in the coming years. Nevertheless, increasing investments in research and clinical trials are likely to create lucrative growth opportunities for the market in the coming years.
Click here to get the short-term and long-term impact of COVID-19 on this Market.
List of Alopecia Treatment Market Manufacturers include:
- Follicum AB
- Concert Pharmaceuticals Inc.
- Daiichi Sankyo
- Johnson & Johnson
- Merck & Co., Inc.,
- Aclaris Therapeutics, Inc.
- Sun Pharmaceutical Industries Ltd.
- Cipla Inc.
- GlaxoSmithKline plc.
- Other Players
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245